Medicine and Dentistry
Diseases
100%
Neoplasm
97%
Malignant Neoplasm
48%
Magnetic Resonance Imaging
38%
Overall Survival
35%
Radiation Therapy
35%
Multiple Myeloma
33%
Cancer
32%
Biopsy Technique
32%
Breast Cancer
29%
Lung
28%
Computer Assisted Tomography
27%
Infection
27%
Clinical Trial
26%
Colorectal Carcinoma
26%
Recurrent Disease
26%
Quality of Life
24%
Systematic Review
23%
Health Care Cost
22%
Surgeon
22%
Metastatic Carcinoma
21%
Prostate Cancer
21%
Prevalence
21%
Bleeding
20%
Liver Transplantation
19%
Apoplexy
19%
Adverse Event
19%
Migraine
19%
Odds Ratio
18%
Hematopoietic Cell
18%
Placebo
17%
Clinician
17%
Pancreas Cancer
16%
Oncology
16%
Endoscopy
16%
Asthma
16%
Headache
15%
Hazard Ratio
15%
Myelofibrosis
15%
Cell Transplantation
14%
Meta-Analysis
14%
Echocardiography
14%
Biological Marker
13%
Disease
13%
Myeloma
12%
Aneurysm
12%
Combination Therapy
12%
Progression Free Survival
12%
Atrial Fibrillation
12%
COVID-19
12%
Liver Graft
12%
Polyp
11%
Radiology
11%
Arm
11%
Kidney Graft
11%
Melanoma
11%
Colonoscopy
11%
Cardiovascular System
10%
Multivariate Analysis
10%
Congestive Heart Failure
10%
Survival Rate
10%
Prognostic Factor
10%
Cancer Therapy
10%
Proton Therapy
10%
Non Small Cell Lung Cancer
9%
Colon
9%
Epileptic Seizure
9%
Randomized Controlled Trial
9%
Body Mass Index
9%
Neck
9%
Pancreas Adenocarcinoma
9%
Adenocarcinoma
9%
Lung Cancer
9%
Medicine
9%
Allograft
9%
Comorbidity
9%
Health Care
9%
Fibrosis
9%
B Cell
9%
Myeloproliferative Neoplasm
9%
Receptor
9%
Lymph Node
9%
Patient-Reported Outcome
9%
Pediatrics
8%
Clear Cell Renal Cell Carcinoma
8%
Emergency Department
8%
Diabetes
8%
Glioblastoma
8%
In Vitro
8%
Chronic Obstructive Pulmonary Disease
8%
Idiopathic Interstitial Pneumonia
8%
Pelvis
8%
Hepatocellular Carcinoma
8%
Idiopathic Pulmonary Fibrosis
8%
Surgical Technique
8%
Colon Carcinoma
8%
Capsule Endoscopy
8%
Drug Megadose
8%
Pathologist
8%
Crohn's Disease
8%
Keyphrases
Tumor
58%
Confidence Interval
53%
Multiple Myeloma
43%
Overall Survival
36%
Magnetic Resonance Imaging
31%
Colorectal Cancer
31%
Asthma
30%
United States
30%
Eosinophils
29%
Mayo Clinic
29%
Clinical Trials
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
24%
Liver Transplantation
23%
Odds Ratio
23%
Placebo
23%
Migraine
23%
Risk Factors
23%
Lung
23%
Clinical Outcomes
22%
Computed Tomography
21%
Hazard Ratio
21%
Parkinson's Disease
20%
Quality of Life
20%
High Risk
20%
Phase II Trial
20%
Meta-analysis
20%
Chemotherapy
19%
Adverse Events
19%
Myeloma
18%
Radiotherapy
18%
Alzheimer's Disease
17%
Phase II Study
16%
Breast Cancer
16%
Headache
15%
Pancreatic Cancer
15%
Radiation Therapy
15%
Transplantation
15%
Myelofibrosis
14%
Mild Cognitive Impairment
14%
Prostate Cancer
14%
Resection
13%
Obesity
13%
Surgeons
13%
Progression-free Survival
13%
Clinical Practice
13%
Clinical Features
13%
Etiology
13%
Malignancy
13%
Myeloproliferative Neoplasms
13%
Cancer Treatment
12%
Radiologists
12%
Atrial Fibrillation
12%
T Cells
12%
Randomized Controlled Trial
12%
Multivariate Analysis
12%
In Cancer
12%
Treatment Options
11%
Systematic Meta-analysis
11%
Liver
11%
Endoscopy
11%
Cholecystokinin Receptor
10%
COVID-19
10%
Gene Expression
10%
Older Adults
10%
Inflammation
10%
Prognostic Factors
10%
Clinically Significant
10%
Treatment Group
10%
Gemcitabine
10%
Disease Progression
10%
Pathophysiology
10%
Cancer Patients
10%
Bone Marrow
10%
Chronic Obstructive Pulmonary Disease
9%
Hematopoietic Cell Transplantation
9%
Chronic Migraine
9%
Body Mass Index
9%
Diffuse Large B-cell Lymphoma (DLBCL)
9%
Histologic
9%
Polyps
9%
Colorectal Cancer Risk
9%
Colonoscopy
9%
Relapsed or Refractory multiple Myeloma
9%
Non-small Cell Lung Cancer (NSCLC)
9%
Adult Patients
9%
Diabetes
9%
Inflammatory Bowel Disease
9%
Hospitalization
9%
Brain Metastases
9%
Patient Management
9%
Lymphoma
9%
Crohn's Disease
9%
No Significant Difference
9%
Cholecystokinin
9%
Mucin 1 (MUC1)
9%
Graft-versus-host Disease (GvHD)
9%
Pathologic
9%
Glioblastoma
8%
Colon Cancer
8%
Randomized Trial
8%